2016-01-19 | Downgrade | Citigroup Inc. | Buy to Neutral | |
2016-01-18 | Downgrade | Leerink Swann | Outperform to Market Perform | |
2015-08-15 | Reiterated Rating | Leerink Swann | Outperform | $6.00 to $8.35 |
2015-08-13 | Boost Price Target | Leerink Swann | $8.00 | |
2015-05-19 | Lower Price Target | Leerink Swann | Outperform | $23.00 to $6.00 |
2014-03-03 | Initiated Coverage | Leerink Swann | Outperform | |
2014-03-03 | Initiated Coverage | Cowen and Company | Outperform | $35.00 |
2014-03-03 | Initiated Coverage | Citigroup Inc. | Buy | $35.00 |
2016-01-19 | Downgrade | Citigroup Inc. | Buy to Neutral | |
2016-01-18 | Downgrade | Leerink Swann | Outperform to Market Perform | |
2015-08-15 | Reiterated Rating | Leerink Swann | Outperform | $6.00 to $8.35 |
2015-08-13 | Boost Price Target | Leerink Swann | $8.00 | |
2015-05-19 | Lower Price Target | Leerink Swann | Outperform | $23.00 to $6.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In EBIO 7 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
Third Rock Ventures, LLC | 4.84M |
Flagship Ventures Fund 2007, L.P. | 1.91M |
Flagship Ventures 2007 General Partner LLC | 1.91M |
BlackRock Institutional Trust Company, N.A. | 0.44M |
KCG Holdings, Inc. | 0.11M |
BlackRock Fund Advisors | 2365 |
State of New Jersey Common Pension Fund A | 0 |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
THIRD ROCK VENTURES LP | 29.75% (4841591) | AGIO / BLUE / EBIO / FMI / |
JAFCO Super V3 Investment Limited Partnership | 11.82% (1923226) | EBIO / |
Celniker Abbie President and CEO | 2.58% (419946) | DYAX / EBIO / |
Boxer Capital, LLC | 1.83% (297860) | EBIO / MRTX / ODT / |
Flagship Ventures Fund 2007, L.P. | 1.80% (293268) | AGIO / EBIO / RCPT / |
LYNCH DANIEL | 0.99% (161430) | BIND / BLUE / EBIO / |
Furfine Eric Steven Chief Science Officer | 0.21% (34648) | EBIO / |
Tubridy Karen L Chief Development Officer | 0.20% (32753) | AKBA / EBIO / |
MCCABE JOHN J Senior Vice President, Finance | 0.04% (5930) | EBIO / |